Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Gene therapy for phenylketonuria.
[classical phenylketonuria]
Classical
phenylketonuria
(
PKU
)
is
an
autosomal
recessive
disorder
caused
by
a
deficiency
of
hepatic
phenylalanine
hydroxylase
(
PAH
)
.
Limitations
of
the
current
dietary
treatment
for
PKU
have
led
to
the
development
of
potential
treatments
based
on
somatic
gene
transfer
.
Three
different
vector
systems
have
been
examined
.
Vectors
derived
from
a
recombinant
retrovirus
or
a
DNA
/
protein
complex
can
efficiently
transduce
the
PAH
cDNA
into
PAH
-
deficient
hepatocytes
in
vitro
,
but
the
application
of
these
vector
systems
is
presently
limited
by
their
low
transduction
efficiency
in
vivo
.
In
contrast
,
a
vector
derived
from
a
recombinant
adenovirus
can
restore
10
%
-
80
%
of
normal
hepatic
PAH
activity
into
PAH
-
deficient
mice
,
which
completely
normalizes
serum
phenylalanine
levels
.
This
treatment
is
transient
and
can
not
be
effectively
re
-administered
due
to
the
presence
of
neutralizing
antibodies
directed
against
the
recombinant
adenoviral
vector
.
However
,
these
findings
suggest
that
PKU
can
be
completely
corrected
by
somatic
gene
therapy
,
and
provide
some
direction
for
the
future
development
of
adenoviral
vectors
.
Diseases
Validation
Diseases presenting
"the presence of neutralizing antibodies directed against the recombinant adenoviral vector"
symptom
classical phenylketonuria
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom